Your browser doesn't support javascript.
loading
A rapid molecular detection tool for toxigenic M1UK  Streptococcus pyogenes.
Brouwer, Stephan; Das, Swairindhree; Hayes, Andrew J; Bertolla, Olivia M; Davies, Mark R; Walker, Mark J; Whiley, David M; Irwin, Adam D; Tickner, Jacob A.
Afiliación
  • Brouwer S; Australian Infectious Diseases Research Centre and Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
  • Das S; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Hayes AJ; Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Bertolla OM; Australian Infectious Diseases Research Centre and Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
  • Davies MR; Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Walker MJ; Australian Infectious Diseases Research Centre and Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
  • Whiley DM; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Irwin AD; Queensland Paediatric Infectious Diseases Sakzewski Laboratory, Centre for Children's Health Research, Queensland Children's Hospital, Brisbane, Queensland, Australia.
  • Tickner JA; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
J Infect Dis ; 2024 Aug 29.
Article en En | MEDLINE | ID: mdl-39206960
ABSTRACT

BACKGROUND:

The gradual replacement of the Streptococcus pyogenes M1global genotype by a newly emergent M1UK variant is a global public health threat warranting increased surveillance. M1UK differs from progenitor M1global genotype by 27 single nucleotide polymorphisms (SNPs) and is characterised by increased speA superantigen expression in vitro.

METHODS:

An allele-specific real-time PCR assay was developed for the rapid detection of M1UK strains. The assay was used in combination with whole-genome sequencing to determine emm (sub)type distribution for 51 invasive (n = 9) and non-invasive (n = 42) S. pyogenes clinical isolates.

RESULTS:

Emm1 was the most prevalent S. pyogenes emm serotype (n = 11) in this set of clinical isolates, with M1UK being the dominant emm1 genotype (4/5 invasive, 3/6 non-invasive isolates). The assay accurately detected M1UK strains. Whole genome sequencing revealed continued presence of Australian M1UK sub-lineages associated with epidemic scarlet fever-causing S. pyogenes in Asia.

CONCLUSIONS:

Our study establishes a suitable target for detection of the toxigenic M1UK, and confirms the maintenance of M1UK strains in Queensland, Australia. This assay can be deployed in laboratories and provides a valuable, cost-effective tool to enhance surveillance of the expanding M1UK clone.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos